does glp 1 cause lightheadedness The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort Pharmacovigilance analysis of neurological adverse

Data Extraction For each included study, detailed data were extracted into a predesigned table

As reported by the New York Times , the Food & Drug Administration (FDA) is likely to lift restrictions on a handful of banned peptides, due in part to urging from Kennedy

234 The p53, interferon-gamma, and NF-B protein levels in the caudate nucleus are significantly higher in PD patients than in controls, whereas p53 levels are not altered in the substantia nigra, putamen, or cerebral cortex

We have a study from 2008 (12) that followed several patients that consumed massive amounts of selenium due to a mislabeled liquid selenium supplement and only 1 person was hospitalized during the incident